{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:51:59Z","timestamp":1775544719520,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09790-6","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T21:19:12Z","timestamp":1751923152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying risk factors of biliary tract cancers using a large Japanese regional insurance claims database"],"prefix":"10.1038","volume":"15","author":[{"given":"Tatsunori","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ariyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"9790_CR1","unstructured":"Cancer Statistics. Japan: Cancer Information Service, National Cancer Center (National Cancer Registry, Ministry of Health, Labour and Welfare, 2019)."},{"key":"9790_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales, J. M. et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13, 261\u2013280 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9790_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"9790_CR4","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/cncr.33476","volume":"127","author":"G Ouyang","year":"2021","unstructured":"Ouyang, G. et al. The global, regional, and National burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: A systematic analysis for the global burden of disease study 2017. Cancer 127, 2238\u20132250 (2021).","journal-title":"Cancer"},{"key":"9790_CR5","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1200\/EDBK_160831","volume":"35","author":"JA Bridgewater","year":"2016","unstructured":"Bridgewater, J. A., Goodman, K. A., Kalyan, A. & Mulcahy, M. F. Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling. Am. Soc. Clin. Oncol. Educ. Book. 35, e194\u2013203 (2016).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"9790_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/oncolo\/oyad063","volume":"28","author":"V Gunchick","year":"2023","unstructured":"Gunchick, V. et al. Survival analysis of 1140 patients with biliary Cancer and benefit from concurrent Renin-Angiotensin antagonists, statins, or aspirin with systemic therapy. Oncologist 28, 531\u2013541 (2023).","journal-title":"Oncologist"},{"key":"9790_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"SI Ilyas","year":"2018","unstructured":"Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K. & Gores, G. J. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat. Rev. Clin. Oncol. 15, 95\u2013111 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9790_CR8","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava, N., Gores, G. J. & Cholangiocarcinoma Lancet ;383:2168\u20132179. (2014).","journal-title":"Lancet"},{"key":"9790_CR9","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","volume":"31","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J. Clin. Oncol. 31, 1188\u20131195 (2013).","journal-title":"J. Clin. Oncol."},{"key":"9790_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ags3.12691","volume":"7","author":"T Ioka","year":"2023","unstructured":"Ioka, T., Shindo, Y., Ueno, M. & Nagano, H. Current progress in perioperative chemotherapy for biliary tract cancer. Ann. Gastroenterol. Surg. 7, 565\u2013571 (2023).","journal-title":"Ann. Gastroenterol. Surg."},{"key":"9790_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jgh3.12576","volume":"5","author":"Y Kai","year":"2021","unstructured":"Kai, Y. et al. Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer. JGH Open. 5, 712\u2013716 (2021).","journal-title":"JGH Open."},{"key":"9790_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jhbp.870","volume":"28","author":"M Nagino","year":"2021","unstructured":"Nagino, M. et al. Clinical practice guidelines for the management of biliary tract cancers 2019: the 3rd english edition. J. Hepatobiliary Pancreat. Sci. 28, 26\u201354 (2021).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"9790_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00534-013-0606-2","volume":"20","author":"Y Morine","year":"2013","unstructured":"Morine, Y. et al. Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J. Hepatobiliary Pancreat. Sci. 20, 472\u2013480 (2013).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"9790_CR14","doi-asserted-by":"publisher","first-page":"618670","DOI":"10.1155\/2013\/618670","volume":"2013","author":"Y Li","year":"2013","unstructured":"Li, Y., Wei, J., Zhao, Z., You, T. & Zhong, M. Pancreaticobiliary maljunction is associated with common bile duct carcinoma: a meta-analysis. ScientificWorldJournal 2013, 618670 (2013).","journal-title":"ScientificWorldJournal"},{"key":"9790_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/cld.633","volume":"9","author":"RW Chapman","year":"2017","unstructured":"Chapman, R. W. Update on primary sclerosing cholangitis. Clin. Liver Dis. 9, 107\u2013110 (2017).","journal-title":"Clin. Liver Dis."},{"key":"9790_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/jhbp.116","volume":"21","author":"Y Suzuki","year":"2014","unstructured":"Suzuki, Y. et al. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years. J. Hepatobiliary Pancreat. Sci. 21, 617\u2013622 (2014).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"9790_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/jhbp.86","volume":"21","author":"S Kubo","year":"2014","unstructured":"Kubo, S. et al. Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan. J. Hepatobiliary Pancreat. Sci. 21, 479\u2013488 (2014).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"9790_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/oemed-2015-103427","volume":"73","author":"S Kumagai","year":"2016","unstructured":"Kumagai, S. et al. Relationship between cumulative exposure to 1,2-dichloropropane and incidence risk of cholangiocarcinoma among offset printing workers. Occup. Environ. Med. 73, 545\u2013552 (2016).","journal-title":"Occup. Environ. Med."},{"key":"9790_CR19","doi-asserted-by":"publisher","first-page":"e0132673","DOI":"10.1371\/journal.pone.0132673","volume":"10","author":"J Xia","year":"2015","unstructured":"Xia, J., Jiang, S-C. & Peng, H-J. Association between liver fluke infection and hepatobiliary pathological changes: A systematic review and Meta-Analysis. PLoS One. 10, e0132673 (2015).","journal-title":"PLoS One"},{"key":"9790_CR20","doi-asserted-by":"publisher","first-page":"e89368","DOI":"10.1371\/journal.pone.0089368","volume":"9","author":"W Borena","year":"2014","unstructured":"Borena, W. et al. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS One. 9, e89368 (2014).","journal-title":"PLoS One"},{"key":"9790_CR21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00404-015-3896-6","volume":"293","author":"P Guo","year":"2016","unstructured":"Guo, P. et al. Number of parity and the risk of gallbladder cancer: a systematic review and dose-response meta-analysis of observational studies. Arch. Gynecol. Obstet. 293, 1087\u20131096 (2016).","journal-title":"Arch. Gynecol. Obstet."},{"key":"9790_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/dmrr.2671","volume":"32","author":"J Gu","year":"2016","unstructured":"Gu, J. et al. Type 2 diabetes mellitus and risk of gallbladder cancer: a systematic review and meta-analysis of observational studies. Diabetes Metab. Res. Rev. 32, 63\u201372 (2016).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"9790_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/00365529309098253","volume":"28","author":"CJ Moerman","year":"1993","unstructured":"Moerman, C. J. et al. Gallstone size and the risk of gallbladder cancer. Scand. J. Gastroenterol. 28, 482\u2013486 (1993).","journal-title":"Scand. J. Gastroenterol."},{"key":"9790_CR24","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1023\/A:1026675329644","volume":"44","author":"TE Scott","year":"1999","unstructured":"Scott, T. E., Carroll, M., Cogliano, F. D., Smith, B. F. & Lamorte, W. W. A case-control assessment of risk factors for gallbladder carcinoma. Dig. Dis. Sci. 44, 1619\u20131625 (1999).","journal-title":"Dig. Dis. Sci."},{"key":"9790_CR25","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1572-0241.2000.02070.x","volume":"95","author":"S Sheth","year":"2000","unstructured":"Sheth, S., Bedford, A. & Chopra, S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am. J. Gastroenterol. 95, 1402\u20131410 (2000).","journal-title":"Am. J. Gastroenterol."},{"key":"9790_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/apt.12655","volume":"39","author":"V Nagaraja","year":"2014","unstructured":"Nagaraja, V. & Eslick, G. D. Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment. Pharmacol. Ther. 39, 745\u2013750 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"9790_CR27","first-page":"593","volume":"23","author":"N Nabatame","year":"2004","unstructured":"Nabatame, N. et al. High risk of gallbladder carcinoma in elderly patients with segmental adenomyomatosis of the gallbladder. J. Exp. Clin. Cancer Res. 23, 593\u2013598 (2004).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"9790_CR28","doi-asserted-by":"publisher","first-page":"154848","DOI":"10.1016\/j.metabol.2021.154848","volume":"123","author":"J-H Park","year":"2021","unstructured":"Park, J-H. et al. Association of prediabetes, diabetes, and diabetes duration with biliary tract cancer risk: A nationwide cohort study. Metabolism 123, 154848 (2021).","journal-title":"Metabolism"},{"key":"9790_CR29","doi-asserted-by":"publisher","first-page":"10387","DOI":"10.1007\/s00432-023-04944-3","volume":"149","author":"B-W Sheng","year":"2023","unstructured":"Sheng, B-W., Zhang, J-Q., Chen, M. & Ma, M. The inverse association between fasting blood glucose and the occurrence of gallbladder cancer in type 2 diabetes mellitus patients: a case-control study. J. Cancer Res. Clin. Oncol. 149, 10387\u201310398 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"9790_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejca.2021.06.052","volume":"155","author":"J-H Park","year":"2021","unstructured":"Park, J-H. et al. Persistent status of metabolic syndrome and risk of cholangiocarcinoma: A Korean nationwide population-based cohort study. Eur. J. Cancer. 155, 97\u2013105 (2021).","journal-title":"Eur. J. Cancer"},{"key":"9790_CR31","first-page":"JE20200480","volume":"advpub","author":"E Nakatani","year":"2021","unstructured":"Nakatani, E., Tabara, Y., Sato, Y., Tsuchiya, A. & Miyachi, Y. Data resource profile of Shizuoka Kokuho database (SKDB) using integrated health- and Care-insurance claims and health checkups: the Shizuoka study. J. Epidemiol. advpub, JE20200480 (2021).","journal-title":"J. Epidemiol."},{"key":"9790_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jdin.2023.04.007","volume":"12","author":"H Hashizume","year":"2023","unstructured":"Hashizume, H., Nakatani, E., Sasaki, H. & Miyachi, Y. Hydrochlorothiazide increases risk of nonmelanoma skin cancer in an elderly Japanese cohort with hypertension: the Shizuoka study. JAAD Int. 12, 49\u201357 (2023).","journal-title":"JAAD Int."},{"key":"9790_CR33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/hae.14793","volume":"29","author":"A Shoji-Asahina","year":"2023","unstructured":"Shoji-Asahina, A. et al. Risk factors, treatment and survival rates of late-onset acquired haemophilia A: A cohort study from the Shizuoka Kokuho database. Haemophilia 29, 799\u2013808 (2023).","journal-title":"Haemophilia"},{"key":"9790_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jdin.2022.12.002","volume":"11","author":"N Ubukata","year":"2023","unstructured":"Ubukata, N., Nakatani, E., Hashizume, H., Sasaki, H. & Miyachi, Y. Risk factors and drugs that trigger the onset of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: A population-based cohort study using the Shizuoka Kokuho database. JAAD Int. 11, 24\u201332 (2023).","journal-title":"JAAD Int."},{"key":"9790_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1507\/endocrj.EJ23-0593","volume":"71","author":"W Ogawa","year":"2024","unstructured":"Ogawa, W. et al. Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocr. J. 71, 223\u2013231 (2024).","journal-title":"Endocr. J."},{"key":"9790_CR36","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan, H. et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care. 43, 1130\u20131139 (2005).","journal-title":"Med. Care"},{"key":"9790_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser, A., Steiner, C., Harris, D. R. & Coffey, R. M. Comorbidity measures for use with administrative data. Med. Care. 36, 8\u201327 (1998).","journal-title":"Med. Care"},{"key":"9790_CR38","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray, W. A. Evaluating medication effects outside of clinical trials: new-user designs. Am. J. Epidemiol. 158, 915\u2013920 (2003).","journal-title":"Am. J. Epidemiol."},{"key":"9790_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.3334","volume":"22","author":"ES Johnson","year":"2013","unstructured":"Johnson, E. S. et al. The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf. 22, 1\u20136 (2013).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"9790_CR40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/EDE.0000000000001628","volume":"34","author":"S Suissa","year":"2023","unstructured":"Suissa, S., Dell\u2019Aniello, S. & Renoux, C. The prevalent New-user design for studies with no active comparator: the example of Statins and Cancer. Epidemiology 34, 681\u2013689 (2023).","journal-title":"Epidemiology"},{"key":"9790_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell, F. E. Jr, Lee, K. L. & Mark, D. B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 15, 361\u2013387 (1996).","journal-title":"Stat. Med."},{"key":"9790_CR42","unstructured":"Gan-joho service. biliary tract cancer [Internet]. [cited 2024 Jul 25]. Available from: https:\/\/ganjoho.jp\/public\/cancer\/biliary_tract\/index.html"},{"key":"9790_CR43","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s12876-022-02637-8","volume":"22","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. The epidemiological trends of biliary tract cancers in the united States of America. BMC Gastroenterol. 22, 546 (2022).","journal-title":"BMC Gastroenterol."},{"key":"9790_CR44","doi-asserted-by":"publisher","first-page":"537","DOI":"10.31557\/APJCP.2024.25.2.537","volume":"25","author":"N Anchalee","year":"2024","unstructured":"Anchalee, N. et al. Spatio-Temporal analysis of cholangiocarcinoma in a high prevalence area of Northeastern thailand: A 10-Year large scale screening program. Asian Pac. J. Cancer Prev. 25, 537\u2013546 (2024).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"9790_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/MEG.0000000000002313","volume":"34","author":"F Baidoun","year":"2022","unstructured":"Baidoun, F., Sarmini, M. T., Merjaneh, Z. & Moustafa, M. A. Controversial risk factors for cholangiocarcinoma. Eur. J. Gastroenterol. Hepatol. 34, 338\u2013344 (2022).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"9790_CR46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jcjd.2020.09.008","volume":"45","author":"C Saengboonmee","year":"2021","unstructured":"Saengboonmee, C., Seubwai, W., Lert-Itthiporn, W., Sanlung, T. & Wongkham, S. Association of diabetes mellitus and cholangiocarcinoma: update of evidence and the effects of antidiabetic medication. Can. J. Diabetes. 45, 282\u2013290 (2021).","journal-title":"Can. J. Diabetes"},{"key":"9790_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001312","author":"T-I Chen","year":"2025","unstructured":"Chen, T-I. et al. Associations between metabolic syndrome and cholangiocarcinoma risk: A large-scale population-based cohort study. Hepatology https:\/\/doi.org\/10.1097\/HEP.0000000000001312 (2025).","journal-title":"Hepatology"},{"key":"9790_CR48","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1123\/jpah.2015-0456","volume":"13","author":"D Aune","year":"2016","unstructured":"Aune, D., Leitzmann, M. & Vatten, L. J. Physical activity and the risk of gallbladder disease: A systematic review and Meta-Analysis of cohort studies. J. Phys. Act. Health. 13, 788\u2013795 (2016).","journal-title":"J. Phys. Act. Health"},{"key":"9790_CR49","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/sj.bjc.6605063","volume":"100","author":"CH Lee","year":"2009","unstructured":"Lee, C. H. et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br. J. Cancer. 100, 1765\u20131770 (2009).","journal-title":"Br. J. Cancer"},{"key":"9790_CR50","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/modpathol.2011.41","volume":"24","author":"T-H Yu","year":"2011","unstructured":"Yu, T-H. et al. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression. Mod. Pathol. 24, 810\u2013819 (2011).","journal-title":"Mod. Pathol."},{"key":"9790_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/1471-2407-12-289","volume":"12","author":"Y Zhou","year":"2012","unstructured":"Zhou, Y. et al. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer. 12, 289 (2012).","journal-title":"BMC Cancer"},{"key":"9790_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12957-015-0583-9","volume":"13","author":"H Li","year":"2015","unstructured":"Li, H. et al. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World J. Surg. Oncol. 13, 161 (2015).","journal-title":"World J. Surg. Oncol."},{"key":"9790_CR53","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3390\/cancers14071709","volume":"14","author":"IR Cho","year":"2022","unstructured":"Cho, I. R., Yi, S-W., Choi, J. S. & Yi, J-J. Comparison of risk factors for cholangiocarcinoma and hepatocellular carcinoma: A prospective cohort study in Korean adults. Cancers 14, 1709 (2022).","journal-title":"Cancers"},{"key":"9790_CR54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1443-1661.2010.00936.x","volume":"22","author":"T Fujimoto","year":"2010","unstructured":"Fujimoto, T. et al. Long-term outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis. Dig. Endosc. 22, 95\u2013100 (2010).","journal-title":"Dig. Endosc"},{"key":"9790_CR55","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.hbpd.2022.08.010","volume":"22","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Occult pancreaticobiliary reflux is a pathogenic factor of some benign biliary diseases and gallbladder cancer. Hepatobiliary Pancreat. Dis. Int. 22, 288\u2013293 (2023).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"9790_CR56","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.3390\/cancers15123092","volume":"15","author":"K Hemminki","year":"2023","unstructured":"Hemminki, K. et al. Population-Attributable fractions of personal comorbidities for liver, gallbladder, and bile duct cancers. Cancers 15, 3092 (2023).","journal-title":"Cancers"},{"key":"9790_CR57","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/sj.bjc.6604047","volume":"97","author":"AW Hsing","year":"2007","unstructured":"Hsing, A. W. et al. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br. J. Cancer. 97, 1577\u20131582 (2007).","journal-title":"Br. J. Cancer"},{"key":"9790_CR58","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1007\/s12035-021-02544-1","volume":"58","author":"A Zab\u0142ocka","year":"2021","unstructured":"Zab\u0142ocka, A. et al. Inverse correlation between alzheimer\u2019s disease and cancer: short overview. Mol. Neurobiol. 58, 6335\u20136349 (2021).","journal-title":"Mol. Neurobiol."},{"key":"9790_CR59","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/ueg2.12281","volume":"10","author":"P Zaccari","year":"2022","unstructured":"Zaccari, P. et al. Risk factors for the occurrence of ampullary tumors: A case-control study. United Eur. Gastroenterol. J. 10, 730\u2013735 (2022).","journal-title":"United Eur. Gastroenterol. J."},{"key":"9790_CR60","doi-asserted-by":"publisher","first-page":"9541","DOI":"10.3748\/wjg.v20.i28.9541","volume":"20","author":"X-D He","year":"2014","unstructured":"He, X-D. et al. Association of metabolic syndromes and risk factors with ampullary tumors development: a case-control study in China. World J. Gastroenterol. 20, 9541\u20139548 (2014).","journal-title":"World J. Gastroenterol."},{"key":"9790_CR61","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.berh.2019.03.011","volume":"32","author":"D De Cock","year":"2018","unstructured":"De Cock, D. & Hyrich, K. Malignancy and rheumatoid arthritis: epidemiology, risk factors and management. Best Pract. Res. Clin. Rheumatol. 32, 869\u2013886 (2018).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"9790_CR62","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.semarthrit.2013.08.003","volume":"43","author":"DH Solomon","year":"2014","unstructured":"Solomon, D. H. et al. Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum. 43, 489\u2013497 (2014).","journal-title":"Semin Arthritis Rheum."},{"key":"9790_CR63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.14442\/jgfm.17.2_132","volume":"17","author":"S Shimoda","year":"2016","unstructured":"Shimoda, S., Chong, Y., Akahoshi, M., Niiro, H. & Tsukamoto, H. Hepatic and Gastrointestinal manifestations in rheumatic and connective tissue diseases. J. Gen. Fam Med. 17, 132\u2013137 (2016).","journal-title":"J. Gen. Fam Med."},{"key":"9790_CR64","doi-asserted-by":"publisher","first-page":"10144","DOI":"10.3748\/wjg.v20.i29.10144","volume":"20","author":"F Rostain","year":"2014","unstructured":"Rostain, F. et al. Trends in incidence and management of cancer of the ampulla of vater. World J. Gastroenterol. 20, 10144\u201310150 (2014).","journal-title":"World J. Gastroenterol."},{"key":"9790_CR65","doi-asserted-by":"publisher","first-page":"1129948","DOI":"10.3389\/fphar.2023.1129948","volume":"14","author":"H Guo","year":"2023","unstructured":"Guo, H. et al. Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis. Front. Pharmacol. 14, 1129948 (2023).","journal-title":"Front. Pharmacol."},{"key":"9790_CR66","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2021.07.030","volume":"156","author":"R Zeng","year":"2021","unstructured":"Zeng, R. et al. Comprehensive analysis of proton pump inhibitors and risk of digestive tract cancers. Eur. J. Cancer. 156, 190\u2013201 (2021).","journal-title":"Eur. J. Cancer"},{"key":"9790_CR67","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1200\/JCO.18.02059","volume":"37","author":"H Ueno","year":"2019","unstructured":"Ueno, H. et al. Prospective multicenter study on the prognostic and predictive impact of tumor budding in stage II colon cancer: results from the SACURA trial. J. Clin. Oncol. 37, 1886\u20131894 (2019).","journal-title":"J. Clin. Oncol."},{"key":"9790_CR68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements, O., Eliahoo, J., Kim, J. U., Taylor-Robinson, S. D. & Khan, S. A. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. J. Hepatol. 72, 95\u2013103 (2020).","journal-title":"J. Hepatol."},{"key":"9790_CR69","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","volume":"8","author":"B Blechacz","year":"2011","unstructured":"Blechacz, B., Komuta, M., Roskams, T. & Gores, G. J. Clinical diagnosis and staging of cholangiocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 8, 512\u2013522 (2011).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09790-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:52:25Z","timestamp":1757209945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09790-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9790"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09790-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24347"}}